DEEMEA

Startup

Deemea is an AI-driven Pharmatech company committed to empowering R&D teams with cutting-edge tools to exploit the value of medical imaging in both de novo or repurposed drug development. From trial strategy and design to operational execution.

Specialist in DeepLearning technologies, Deemea has developed an AI-driven Research platform, for pharmaceutical and biotech companies to leverage medical imaging in their R&D activities - to innovate and progress through trial stages confidently : 

• our multimodal data collection, structuring, management and enrichment applications massively reduce operational time
• our data mining and standardized image interpretation applications accelerate exploratory studies
• our data pipeline applications facilitate the development and validation of models and algorithms to test trial hypothesis, assess clinical endpoints or develop novel biomarkers (e.g. companion diagnostics, therapeutic response)

Deemea Research enables pharma and biotech companies to accelerate, standardize, and enhance accuracy of their innovation : Deemea AI-guided platform streamlines the re-use of internal data and integration with external datasets.

Deemea also supports pharma companies in their Clinical operations - to conduct data-intensive and massively multicentric clinical studies: our collaborative workflow management applications deliver cost savings, ensure GCP and regulatory compliance, and improve efficiency and engagement of clinicians and study coordinators.

website